RS
GILD icon

R Squared’s Gilead Sciences GILD Stock Holding History

R Squared’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$448K Buy
+3,544
New +$467K 0.24% 119
2025
Q4 		– Sell
-8,829
Closed -$980K – 605
2025
Q3 		$980K Sell
8,829
-4,538
-34% -$516K 0.42% 50
2025
Q2 		$1.48M Buy
13,367
+7,077
+113% +$753K 0.82% 16
2025
Q1 		$705K Buy
+6,290
New +$649K 0.75% 25

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

R Squared's GILD Position: Q2 2026 in Review

R Squared opened a new position in Gilead Sciences (GILD) in Q2 2026: 3,544 shares worth $448K. The stake represents 0.24% of the portfolio and ranks #119 among its holdings. This is a return to the name: R Squared previously reported a position in GILD as recently as Q3 2025.

R Squared first reported a position in GILD in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.48M in Q2 2025. 2,272 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • R Squared held 3,544 shares of Gilead Sciences worth $448K as of Q2 2026.
  • Gilead Sciences was a new R Squared position in Q2 2026.
  • Gilead Sciences made up 0.24% of R Squared's portfolio in Q2 2026, its #119 holding.
  • R Squared first reported a position in Gilead Sciences in Q1 2025 and has held it in 4 quarters since.
  • R Squared's Gilead Sciences position peaked at $1.48M in Q2 2025.
  • 2,272 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.